SS-31 in Mitochondrial Research: A Reference Guide

SS-31, also known as Elamipretide, stands as a prominent research tool for investigating mitochondrial biology due to its unique mitochondria-targeted mechanism and influence on cardiolipin and cellular bioenergetics. Its specific interactions within the inner mitochondrial membrane make it an invaluable agent for exploring pathways related to mitochondrial dysfunction and oxidative stress. The extensive body of work surrounding SS-31 is evidenced by over 122 indexed publications on PubMed and a registered study on ClinicalTrials.gov, reflecting sustained scientific interest in its foundational biological roles.

This reference page provides a comprehensive overview of SS-31 for research-use-only applications, detailing its molecular characteristics, established mechanisms of action, and diverse applications in mitochondrial research models. Researchers can utilize this information to inform experimental design, interpret findings, and explore new avenues in the study of mitochondrial health and disease.

Introduction to SS-31 as a Mitochondrial Research Tool

SS-31, also known by its research alias Elamipretide, stands as a prominent and extensively investigated research peptide within the realm of mitochondrial biology and regenerative science. Classified fundamentally as a mitochondria-targeted peptide, its unique molecular architecture has positioned it as an invaluable probe for dissecting intricate mitochondrial functions. The peptide’s selective accumulation within the inner mitochondrial membrane, a characteristic feature that distinguishes it from many other compounds, allows researchers to explore targeted interventions in cellular bioenergetics, membrane integrity, and oxidative defense systems with remarkable precision. Its utility spans a broad spectrum of preclinical investigations, making it a critical tool for understanding the pathology and potential modulation of mitochondrial dysfunction across various physiological and pathological contexts.

The scientific community’s interest in SS-31 is evidenced by its robust publication record. With 122 indexed publications on PubMed, the breadth and depth of research into SS-31 are substantial, covering its fundamental mechanisms to its potential implications in complex biological systems. These studies collectively contribute to a growing body of knowledge regarding how specific mitochondrial targeting can influence overall cellular health and disease progression. Furthermore, the initiation of 1 registered study on ClinicalTrials.gov underscores a continued translational interest, indicating that research insights derived from SS-31 studies are being explored for their broader biological significance.

The primary research focus areas for SS-31 revolve around its impact on cardiolipin and mitochondrial bioenergetics. Cardiolipin, a unique phospholipid crucial for mitochondrial membrane stability and function, is a direct target of SS-31’s action. By modulating cardiolipin dynamics, SS-31 influences a cascade of downstream mitochondrial processes, including electron transport chain efficiency, ATP production, and the generation of reactive oxygen species. Consequently, SS-31 has become a go-to research tool for investigators seeking to understand the fundamental interplay between mitochondrial structure and function, offering a unique avenue to explore how fine-tuning mitochondrial processes can impact cellular resilience and adaptation under stress.

As researchers continue to uncover the multifaceted roles of mitochondria in health and disease, SS-31 provides an indispensable experimental leverage. Its defined mechanism, coupled with its extensive research history, offers a reliable platform for hypothesis testing in studies ranging from basic molecular biology to complex physiological models of disease. This reference guide aims to consolidate the current understanding of SS-31’s properties, mechanisms, and research applications, serving as a comprehensive resource for scientists engaged in mitochondrial research.

Molecular Structure and Mitochondrial Targeting Mechanism of SS-31

SS-31, chemically known as D-Arg-Dmt-Lys-Phe-NH2, is a synthetic tetrapeptide characterized by its distinct molecular architecture that confers its highly specific mitochondrial targeting ability. The peptide consists of four amino acid residues arranged in a specific sequence: D-arginine (D-Arg), 2′,6′-dimethyltyrosine (Dmt), L-lysine (Lys), and L-phenylalanine (Phe), with an amide group at the C-terminus. The strategic inclusion of D-amino acids, particularly D-arginine, contributes to its proteolytic stability, an important consideration for research involving SS-31 in complex biological matrices where enzymatic degradation could be a limiting factor. The Dmt residue, a synthetic tyrosine derivative, is critical for its antioxidant properties and interaction with membrane phospholipids.

The defining feature of SS-31 is its highly efficient and selective mitochondrial targeting. This mechanism is primarily attributed to a combination of its positive charge and lipophilic nature. At physiological pH, SS-31 carries a net positive charge due to the presence of basic residues (arginine and lysine). Mitochondria maintain a substantial electrical potential difference across their inner membrane, with the matrix side being negatively charged relative to the intermembrane space. This strong electrochemical gradient, estimated at approximately -150 to -180 mV, acts as a powerful electrophoretic force, attracting positively charged molecules directly into the mitochondrial matrix.

Upon entering the mitochondrial compartment, SS-31 specifically localizes to the inner mitochondrial membrane, which is a critical site for its functional activity. A key aspect of SS-31’s mechanism of action involves its preferential interaction with cardiolipin. Cardiolipin is a unique, negatively charged phospholipid almost exclusively found in the inner mitochondrial membrane, where it plays a crucial role in maintaining membrane integrity, facilitating electron transport chain supercomplex assembly, and regulating various mitochondrial protein functions. The positive charge of SS-31 enables it to electrostatically interact with the negatively charged headgroups of cardiolipin molecules, anchoring the peptide within the inner membrane.

Mechanism of Mitochondrial Entry and Localization

The journey of SS-31 into the mitochondria involves several steps:

Plasma Membrane Permeation: Due to its relatively small size and moderate lipophilicity, SS-31 can traverse the cellular plasma membrane and enter the cytoplasm.
Mitochondrial Outer Membrane Passage: The outer mitochondrial membrane is permeable to small molecules through porin channels, allowing SS-31 to reach the intermembrane space.
Inner Mitochondrial Membrane Translocation: This is the crucial step driven by the strong negative mitochondrial membrane potential. The positive charge of SS-31 facilitates its electrophoretic movement across the inner mitochondrial membrane and into the matrix, where it subsequently binds to cardiolipin.

This multi-step, potential-driven delivery ensures that SS-31 achieves high concentrations specifically within the mitochondrial compartment, where it can exert its effects on bioenergetic processes and oxidative stress modulation.

The highly localized distribution of SS-31 to the inner mitochondrial membrane, facilitated by its specific interaction with cardiolipin, underscores its utility as a targeted research agent. Unlike broader-acting compounds, SS-31 allows researchers to investigate the direct consequences of modulating inner mitochondrial membrane properties without widespread off-target effects in other cellular compartments. This specificity is invaluable for isolating and understanding the precise molecular mechanisms underlying mitochondrial dysfunction and for evaluating the impact of such targeted interventions on cellular physiology.

SS-31’s Role in Cardiolipin Remodeling and Stability Research

Cardiolipin is a unique, dimeric phospholipid predominantly found in the inner mitochondrial membrane, where it constitutes approximately 10-20% of the total lipid content. Its distinctive conical shape, coupled with its four acyl chains and two phosphate groups, makes it essential for maintaining the structural integrity and functionality of the mitochondrial inner membrane. Cardiolipin plays critical roles in a multitude of mitochondrial processes, including the organization and activity of electron transport chain (ETC) supercomplexes, regulation of mitochondrial protein import, and involvement in mitochondrial dynamics and apoptosis. Dysfunctional cardiolipin remodeling or altered cardiolipin content is implicated in numerous mitochondrial pathologies, making it a key area of investigation in regenerative biology and disease research.

SS-31’s interaction with cardiolipin is central to its observed effects and is a primary focus of research. The positively charged SS-31 peptide is thought to bind electrostatically to the negatively charged headgroups of cardiolipin molecules within the inner mitochondrial membrane. This interaction is not merely superficial; research suggests that SS-31 can stabilize cardiolipin, influencing its conformation and interactions with other membrane proteins. In situations of oxidative stress or mitochondrial damage, cardiolipin is particularly susceptible to peroxidation, leading to its degradation and subsequent impairment of mitochondrial function. By interacting with cardiolipin, SS-31 is hypothesized to protect it from oxidative damage, thereby preserving its crucial roles in membrane integrity and enzyme activity.

Impact on Cardiolipin Structure and Function

Research into SS-31’s role in cardiolipin remodeling and stability investigates several key areas:

Protection from Peroxidation: Studies indicate that SS-31 can reduce cardiolipin oxidation, a critical step in mitochondrial dysfunction. This protective effect helps maintain the structural integrity of the inner mitochondrial membrane, which is vital for efficient electron transport and ATP synthesis.
Stabilization of ETC Supercomplexes: Cardiolipin is known to be essential for the formation and stability of respiratory supercomplexes (e.g., Complex I/III/IV supercomplexes). By preserving cardiolipin’s integrity, SS-31 may indirectly contribute to the optimal assembly and function of these supercomplexes, thus supporting efficient electron flow and reducing electron leakage.
Modulation of Membrane Permeability: Healthy cardiolipin is critical for maintaining the selective permeability of the inner mitochondrial membrane. Damage to cardiolipin can lead to increased non-specific permeability, potentially triggering mitochondrial swelling and the release of pro-apoptotic factors. SS-31’s interaction with cardiolipin may help prevent such detrimental changes, thereby maintaining mitochondrial homeostasis.

Investigations utilizing SS-31 have provided significant insights into the dynamic interplay between cardiolipin integrity and mitochondrial function. For instance, studies in models of ischemia-reperfusion injury or aging often demonstrate that cardiolipin levels and composition are altered, contributing to mitochondrial dysfunction. Administration of SS-31 in these research models has been shown to mitigate these changes, suggesting its potential to normalize cardiolipin profiles and restore mitochondrial functional parameters. This makes SS-31 an invaluable probe for researchers studying conditions where cardiolipin damage is a primary driver of pathology, offering a means to explore targeted interventions aimed at preserving this vital mitochondrial phospholipid.

In essence, SS-31 serves as a molecular chaperone for cardiolipin, safeguarding its structure and ensuring its proper function under stress conditions. Its ability to specifically target and interact with cardiolipin within the inner mitochondrial membrane offers a powerful research avenue for dissecting the precise mechanisms by which cardiolipin integrity influences the broader landscape of mitochondrial health and disease. Understanding these interactions is fundamental for developing a deeper comprehension of mitochondrial adaptive responses and vulnerabilities.

Impact of SS-31 on Mitochondrial Bioenergetics and ATP Production

Mitochondria are universally recognized as the powerhouses of the cell, primarily responsible for generating adenosine triphosphate (ATP) through oxidative phosphorylation. This complex process, termed mitochondrial bioenergetics, involves the coordinated action of the electron transport chain (ETC) and ATP synthase, all intricately embedded within the inner mitochondrial membrane. Any disruption to the efficiency of these systems can profoundly impact cellular function and viability. SS-31, through its unique mitochondrial targeting and interaction with cardiolipin, has emerged as a significant research tool for investigating the modulation of mitochondrial bioenergetics and ATP production in various experimental models.

The core of SS-31’s impact on bioenergetics stems from its protective and stabilizing effects on the inner mitochondrial membrane, particularly through its interaction with cardiolipin. As discussed, cardiolipin is indispensable for the optimal assembly and function of ETC supercomplexes, which are crucial for efficient electron flow and minimizing reactive oxygen species (ROS) production. By preserving cardiolipin integrity and preventing its oxidative degradation, SS-31 helps maintain the structural framework necessary for the ETC to operate at peak efficiency. This stabilization promotes stable interactions between ETC complexes, ensuring a robust proton gradient across the inner membrane, which is the driving force for ATP synthesis.

Key Bioenergetic Parameters Influenced by SS-31

Research using SS-31 consistently demonstrates its capacity to improve several critical parameters of mitochondrial bioenergetics:

Oxygen Consumption Rate (OCR): Studies often show that SS-31 can restore or enhance OCR in compromised mitochondria, indicating improved electron flow through the ETC. This suggests a more efficient utilization of oxygen for energy production.
Mitochondrial Membrane Potential (Ψ_m): A robust mitochondrial membrane potential is essential for ATP synthesis. SS-31 has been observed to help maintain or restore Ψ_m, signifying a healthier and more active mitochondrial state capable of supporting high rates of oxidative phosphorylation.
ATP Production: Direct measurements frequently reveal that SS-31 can increase cellular and mitochondrial ATP levels, particularly under conditions of bioenergetic stress. This enhancement is a direct consequence of improved ETC efficiency and ATP synthase activity.
Respiratory Control Ratio (RCR): The RCR, a measure of mitochondrial coupling efficiency, is often improved by SS-31, reflecting a better balance between electron transport and ATP synthesis, with less proton leak.

The ability of SS-31 to positively influence mitochondrial bioenergetics has been demonstrated across diverse research paradigms. For example, in models of metabolic dysfunction, ischemia-reperfusion injury, or neurodegenerative conditions, mitochondria often exhibit reduced respiratory capacity and ATP deficits. Investigations have shown that interventions with SS-31 can mitigate these bioenergetic declines, suggesting a role in cellular resilience and functional recovery. Researchers utilize SS-31 to probe how targeted enhancement of mitochondrial efficiency can impact cellular responses to stress, metabolic regulation, and overall tissue viability. Its distinct action provides a valuable investigative lens to understand the therapeutic potential derived from directly bolstering mitochondrial energy machinery.

In summary, SS-31 serves as an indispensable research tool for understanding and modulating mitochondrial bioenergetics. Its mechanism, primarily through cardiolipin stabilization and subsequent optimization of ETC function, leads to enhanced ATP production and improved mitochondrial efficiency. This makes it a crucial compound for studies focused on energy metabolism, cellular adaptation to stress, and the pathophysiology of diseases characterized by bioenergetic compromise, providing critical insights into how targeted mitochondrial support can influence cellular outcomes.

SS-31 in Oxidative Stress and Reactive Oxygen Species Modulation Studies

Mitochondria are central to cellular metabolism and are simultaneously significant producers of reactive oxygen species (ROS) as byproducts of oxidative phosphorylation. While low levels of ROS are important for cellular signaling, excessive or uncontrolled ROS generation leads to oxidative stress, a state characterized by an imbalance between ROS production and the cell’s antioxidant defense mechanisms. Oxidative stress can damage crucial cellular components, including lipids, proteins, and DNA, contributing significantly to cellular dysfunction, aging, and the pathogenesis of numerous diseases. Research into compounds that can modulate mitochondrial ROS production and mitigate oxidative damage is therefore of paramount importance, and SS-31 has emerged as a key investigative agent in this domain.

SS-31’s role in modulating oxidative stress is multifaceted and intricately linked to its effects on mitochondrial bioenergetics and cardiolipin stability. One of the primary mechanisms by which SS-31 is believed to reduce ROS production is by improving the efficiency of the electron transport chain (ETC). When the ETC is compromised or “leaky,” electrons can prematurely escape and react with oxygen to form superoxide radicals (O₂⁻), a major precursor to other harmful ROS. By stabilizing cardiolipin and promoting the optimal assembly and function of ETC supercomplexes, SS-31 helps to ensure smooth and efficient electron flow, thereby reducing the likelihood of electron leakage and subsequent ROS generation.

Mechanisms of Oxidative Stress Modulation

SS-31 modulates oxidative stress through several proposed mechanisms within the mitochondrial environment:

Enhanced ETC Efficiency: By preserving cardiolipin and optimizing supercomplex formation, SS-31 facilitates more efficient electron transport, reducing the generation of superoxide from Complexes I and III.
Direct Antioxidant Activity: The Dmt residue within SS-31 possesses intrinsic antioxidant properties. While its primary role might be structural, this residue can potentially scavenge free radicals directly within the mitochondrial inner membrane, where ROS are predominantly generated.
Protection of Mitochondrial Lipids: SS-31’s interaction with cardiolipin shields this critical phospholipid from peroxidation. Oxidized cardiolipin can disrupt membrane integrity and promote further ROS generation, so its protection is vital for maintaining mitochondrial health.
Restoration of Mitochondrial Membrane Potential: By improving bioenergetics, SS-31 helps maintain a healthy mitochondrial membrane potential, which is inversely correlated with ROS production. A depolarized membrane can exacerbate ROS generation, while a stable potential reduces this risk.

Numerous *in vitro* and *in vivo* studies have utilized SS-31 to investigate its capacity to mitigate oxidative damage in models of disease. For instance, in research paradigms of neurodegenerative disorders, ischemia-reperfusion injury, or metabolic diseases, excessive mitochondrial ROS production is a common pathological feature. Investigations have consistently shown that SS-31 can significantly reduce markers of oxidative stress, such as lipid peroxidation products (e.g., malondialdehyde), protein carbonylation, and DNA oxidative lesions (e.g., 8-hydroxy-2′-deoxyguanosine), within affected tissues. These findings highlight SS-31 as a powerful research tool for understanding the consequences of mitochondrial ROS and exploring strategies to modulate cellular oxidative balance.

The specific targeting of SS-31 to the mitochondria allows researchers to study the effects of antioxidant intervention precisely where ROS are primarily generated, offering distinct advantages over more broadly acting antioxidants. This localized action makes SS-31 particularly valuable for dissecting the contribution of mitochondrial oxidative stress to overall cellular pathology and for evaluating the efficacy of targeted mitochondrial support in ameliorating oxidative damage. Its continued exploration provides vital insights into the fundamental mechanisms of oxidative stress and potential avenues for regenerative interventions.

Research Applications Across Diverse Mitochondrial Dysfunction Models

Mitochondrial dysfunction is a pervasive pathological feature implicated in a vast array of human diseases, ranging from neurodegenerative disorders and cardiovascular diseases to metabolic syndromes, aging, and cancer. Given SS-31’s specific targeting to the inner mitochondrial membrane and its demonstrated ability to improve bioenergetics, stabilize cardiolipin, and modulate oxidative stress, it has become an invaluable research tool across a diverse spectrum of mitochondrial dysfunction models. Its utility lies in its capacity to probe fundamental disease mechanisms and evaluate the impact of targeted mitochondrial support in various complex biological systems, helping researchers unravel the intricate roles of mitochondria in health and disease.

Major Research Areas and Models Utilizing SS-31

The breadth of SS-31 research applications reflects the widespread involvement of mitochondrial dysfunction in disease:

Neurodegenerative Diseases: SS-31 has been extensively studied in models of Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis (ALS). In these models, mitochondrial dysfunction, including impaired energy metabolism, increased oxidative stress, and altered mitochondrial dynamics, is a hallmark. Research using SS-31 aims to investigate whether improving mitochondrial function can mitigate neuronal damage, preserve synaptic integrity, and improve behavioral outcomes.
Cardiovascular Diseases: Ischemia-reperfusion injury in myocardial infarction and stroke are significant research areas. During ischemia, oxygen deprivation severely compromises mitochondrial function, followed by a burst of ROS production and further damage upon reperfusion. SS-31 is used to study its potential to protect mitochondria during these critical periods, reduce infarct size, and improve cardiac or cerebral function in experimental models.
Aging and Age-Related Disorders: Mitochondrial dysfunction is a key theory of aging. Researchers employ SS-31 in models of accelerated aging or in older animals to investigate its effects on mitochondrial health, cellular senescence markers, muscle function, and overall lifespan, aiming to understand the potential of mitochondrial support to mitigate age-related decline.
Metabolic Disorders: Conditions like diabetes, obesity, and non-alcoholic fatty liver disease (NAFLD) are often characterized by mitochondrial impairments in metabolically active tissues such as the liver, muscle, and adipose tissue. SS-31 is utilized to explore its impact on insulin sensitivity, glucose homeostasis, lipid metabolism, and organ damage in these experimental models.
Kidney Diseases: Acute kidney injury (AKI) and chronic kidney disease (CKD) involve significant mitochondrial damage in renal tubular cells. Research with SS-31 investigates its protective effects against oxidative stress and bioenergetic compromise in kidney injury models, aiming to preserve renal function.
Musculoskeletal Disorders: Skeletal muscle atrophy, sarcopenia, and myopathies often present with mitochondrial dysfunction. SS-31 is studied to assess its role in preserving muscle mass, enhancing mitochondrial biogenesis, and improving muscle performance and regeneration in relevant animal models.

In these diverse models, SS-31 serves not merely as an intervention but also as a critical probe. By observing how specific improvements in mitochondrial cardiolipin stability, bioener

Frequently Asked Questions

What is SS-31, and what are its aliases?

SS-31 is a synthetic, mitochondria-targeted tetrapeptide. It is also widely known by its alias, Elamipretide, in the scientific literature.

How does SS-31 specifically target mitochondria for research purposes?

SS-31 possesses a unique lipophilic-cationic structure that facilitates its selective accumulation within the inner mitochondrial membrane, driven by the mitochondrial membrane potential. This allows it to interact directly with mitochondrial components, particularly cardiolipin.

What is the primary mechanism of action of SS-31 explored in research?

Research indicates that SS-31’s primary mechanism involves its interaction with cardiolipin, a phospholipid critical for the structural integrity and function of the inner mitochondrial membrane. This interaction is thought to stabilize cardiolipin, preserve mitochondrial cristae structure, and optimize electron transport chain activity.

In what specific areas of mitochondrial research is SS-31 commonly utilized?

SS-31 is extensively studied in research areas focusing on mitochondrial bioenergetics, ATP production, cardiolipin dynamics, oxidative stress, reactive oxygen species (ROS) modulation, and various models of mitochondrial dysfunction and cellular injury.

How many research publications and clinical studies are associated with SS-31?

As of the latest review, SS-31 has been featured in over 122 indexed publications on PubMed and has one registered study on ClinicalTrials.gov, indicating a significant body of research.

Can SS-31 be used in both in vitro and in vivo research models?

Yes, SS-31 has demonstrated efficacy as a research tool in a wide range of *in vitro* models, including isolated mitochondria and various cell lines, as well as in diverse *in vivo* animal models designed to investigate mitochondrial dysfunction.

Are there any known off-target effects of SS-31 observed in research models?

While SS-31 is highly targeted to mitochondria, some research models may explore potential interactions with other cellular components or pathways. Comprehensive experimental design is crucial to delineate specific mitochondrial effects from any broader cellular responses.

What is the recommended storage and handling for SS-31 research reagents?

For optimal research reagent integrity, SS-31 typically requires storage at -20°C or colder, protected from light and moisture. Researchers should consult specific product datasheets for detailed instructions on reconstitution, aliquoting, and long-term storage to maintain experimental consistency.

Scientific References

All information from Royal Peptide Labs is provided for in-vitro laboratory and research use only — not for human, veterinary, diagnostic, or therapeutic use.